The estimated Net Worth of Steven Mc Phail is at least $217 Tysiąc dollars as of 20 February 2019. Steven Phail owns over 3,722 units of Standard BioTools Inc stock worth over $216,727 and over the last 9 years Steven sold FLDM stock worth over $0.
Steven has made over 13 trades of the Standard BioTools Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Steven exercised 3,722 units of FLDM stock worth $13,809 on 20 February 2019.
The largest trade Steven's ever made was buying 20,000 units of Standard BioTools Inc stock on 8 August 2017 worth over $60,000. On average, Steven trades about 1,842 units every 34 days since 2015. As of 20 February 2019 Steven still owns at least 58,417 units of Standard BioTools Inc stock.
You can see the complete history of Steven Phail stock trades at the bottom of the page.
Steven's mailing address filed with the SEC is FLUIDIGM CORPORATION, 7000 SHORELINE COURT, SUITE 100, SOUTH SAN FRANCISCO, CA, 94080.
Over the last 14 years, insiders at Standard BioTools Inc have traded over $29,087,682 worth of Standard BioTools Inc stock and bought 4,143,303 units worth $24,269,186 . The most active insiders traders include Easterly Partners Llcle Par..., Capital Strategies, L.P.Lev... oraz Samuel D Colella. On average, Standard BioTools Inc executives and independent directors trade stock every 9 days with the average trade being worth of $72,208. The most recent stock trade was executed by Nicolas Barthelemy on 1 April 2022, trading 20,993 units of FLDM stock currently worth $78,514.
Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Using proprietary CyTOF® and microfluidics technologies, it develops, manufactures, and markets multi-omic solutions to drive meaningful insights in health and disease, identify biomarkers to inform decisions, and accelerate the development of more effective therapies. Its customers are leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide. Together with them, the Company strives to increase the quality of life for all.
Standard BioTools Inc executives and other stock owners filed with the SEC include: